skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Epitope-dependent mechanisms of CD27 neutralization revealed by X-ray crystallography

Authors:
; ; ; ; ; ; ; ; ;
Publication Date:
Sponsoring Org.:
USDOE
OSTI Identifier:
1413767
Grant/Contract Number:
AC02-06CH11357
Resource Type:
Journal Article: Publisher's Accepted Manuscript
Journal Name:
Molecular Immunology
Additional Journal Information:
Journal Volume: 83; Journal Issue: C; Related Information: CHORUS Timestamp: 2017-12-15 22:12:50; Journal ID: ISSN 0161-5890
Publisher:
Elsevier
Country of Publication:
United Kingdom
Language:
English

Citation Formats

Obmolova, Galina, Teplyakov, Alexey, Malia, Thomas J., Wunderler, Nicole, Kwok, Deborah, Barone, Linda, Sweet, Raymond, Ort, Tatiana, Scully, Michael, and Gilliland, Gary L. Epitope-dependent mechanisms of CD27 neutralization revealed by X-ray crystallography. United Kingdom: N. p., 2017. Web. doi:10.1016/j.molimm.2017.01.005.
Obmolova, Galina, Teplyakov, Alexey, Malia, Thomas J., Wunderler, Nicole, Kwok, Deborah, Barone, Linda, Sweet, Raymond, Ort, Tatiana, Scully, Michael, & Gilliland, Gary L. Epitope-dependent mechanisms of CD27 neutralization revealed by X-ray crystallography. United Kingdom. doi:10.1016/j.molimm.2017.01.005.
Obmolova, Galina, Teplyakov, Alexey, Malia, Thomas J., Wunderler, Nicole, Kwok, Deborah, Barone, Linda, Sweet, Raymond, Ort, Tatiana, Scully, Michael, and Gilliland, Gary L. Wed . "Epitope-dependent mechanisms of CD27 neutralization revealed by X-ray crystallography". United Kingdom. doi:10.1016/j.molimm.2017.01.005.
@article{osti_1413767,
title = {Epitope-dependent mechanisms of CD27 neutralization revealed by X-ray crystallography},
author = {Obmolova, Galina and Teplyakov, Alexey and Malia, Thomas J. and Wunderler, Nicole and Kwok, Deborah and Barone, Linda and Sweet, Raymond and Ort, Tatiana and Scully, Michael and Gilliland, Gary L.},
abstractNote = {},
doi = {10.1016/j.molimm.2017.01.005},
journal = {Molecular Immunology},
number = C,
volume = 83,
place = {United Kingdom},
year = {Wed Mar 01 00:00:00 EST 2017},
month = {Wed Mar 01 00:00:00 EST 2017}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record at 10.1016/j.molimm.2017.01.005

Citation Metrics:
Cited by: 2works
Citation information provided by
Web of Science

Save / Share:
  • CD27 is a T and B cell co-stimulatory protein of the TNF receptor superfamily dependent on the availability of the TNF-like ligand CD70. Two anti-CD27 neutralizing monoclonal antibodies were obtained from mouse hybridoma and subsequently humanized and optimized for binding the target. The two antibodies are similar in terms of their CD27-binding affinity and ability to block NF-κB signaling, however their clearance rates in monkeys are very different. The pharmacokinetics profiles could be epitope dependent. To identify the epitopes, we determined the crystal structure of the ternary complex between CD27 and the Fab fragments of these non-competing antibodies. The structuremore » reveals the binding modes of the antibodies suggesting that their mechanisms of action are distinctly different and provides a possible explanation of the in vivo data.« less
  • The X-ray crystal structure of the substrate-free form of phycocyanobilin (PCB)-ferredoxin oxidoreductase (PcyA; EC 1.3.7.5) from the cyanobacterium Nostoc sp. PCC7120 has been solved at 2.5 angstrom resolution. A comparative analysis of this structure with those recently reported for substrate-bound and substrate-free forms of PcyA from the cyanobacterium Synechocystis sp. PCC6803 (Hagiwara et al. (2006) Proc. Natl. Acad. Sci. U.S.A. 103, 27-32; Hagiwara et al. (2006) FEBS Lett. 580, 3823-3828) provides a compelling picture of substrate-induced changes in the PcyA enzyme and the chemical basis of PcyA's catalytic activity. On the basis of these structures and the biochemical analysis ofmore » site-directed mutants of Nostoc PcyA, including mutants reported in recent studies (Tu et al. (2006) J. Biol. Chem. 281, 3127-3136) as well as mutants described in this study, a revised mechanism for the PcyA-mediated four-electron reduction of biliverdin IX{alpha} to 3E/3Z-phycocyanobilin via enzyme-bound bilin radical intermediates is proposed. The mechanistic insight of these studies, along with homology modeling, have provided new insight into the catalytic mechanisms of other members of the ferredoxin-dependent bilin reductase family that are widespread in oxygenic photosynthetic organisms.« less
  • Elevated levels of copper or silver ions in the environment are an immediate threat to many organisms. Escherichia coli is able to resist the toxic effects of these ions through strictly limiting intracellular levels of Cu(I) and Ag(I). The CusCFBA system is one system in E. coli responsible for copper/silver tolerance. A key component of this system is the periplasmic copper/silver-binding protein, CusF. Here the X-ray structure and XAS data on the CusF-Ag(I) and CusF-Cu(I) complexes, respectively, are reported. In the CusF-Ag(I) structure, Ag(I) is coordinated by two methionines and a histidine, with a nearby tryptophan capping the metal site.more » EXAFS measurements on the CusF-Cu(I) complex show a similar environment for Cu(I). The arrangement of ligands effectively sequesters the metal from its periplasmic environment and thus may play a role in protecting the cell from the toxic ion.« less
  • G protein-coupled receptors (GPCRs) represent a large fraction of current pharmaceutical targets, and of the GPCRs, the {beta}{sub 2} adrenergic receptor ({beta}{sub 2}AR) is one of the most extensively studied. Previously, the X-ray crystal structure of {beta}{sub 2}AR has been determined in complex with two partial inverse agonists, but the global impact of additional ligands on the structure or local impacts on the binding site are not well-understood. To assess the extent of such ligand-induced conformational differences, we determined the crystal structures of a previously described engineered {beta}{sub 2}AR construct in complex with two inverse agonists: ICI 118,551 (2.8 {angstrom}),more » a recently described compound (2.8 {angstrom}) (Kolb et al, 2009), and the antagonist alprenolol (3.1 {angstrom}). The structures show the same overall fold observed for the previous {beta}{sub 2}AR structures and demonstrate that the ligand binding site can accommodate compounds of different chemical and pharmacological properties with only minor local structural rearrangements. All three compounds contain a hydroxy-amine motif that establishes a conserved hydrogen bond network with the receptor and chemically diverse aromatic moieties that form distinct interactions with {beta}{sub 2}AR. Furthermore, receptor ligand cross-docking experiments revealed that a single {beta}{sub 2}AR complex can be suitable for docking of a range of antagonists and inverse agonists but also indicate that additional ligand-receptor structures may be useful to further improve performance for in-silico docking or lead-optimization in drug design.« less